Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost semaglutide side effects are gastrointestinal, arrive in the first few weeks of treatment, and settle on their own. That's the honest short answer. The longer one is that "raw" reactions vary widely between people — some barely notice anything; others spend a fortnight feeling genuinely rough before their body adjusts. The NHS medicines page for semaglutide lists the full profile, and this page walks through what those effects feel like in practice, which ones need a call to your prescriber, and the handful of rarer reactions that warrant urgent medical attention. Semaglutide (sold as Wegovy for weight management) is a prescription-only medicine; whether it's suitable for you is a clinical decision, not something a side-effect list can settle on its own.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you've done your first injection, you're feeling cautiously optimistic, and then on day three the nausea arrives. It often comes in waves rather than sitting constantly, and it tends to be worst when you eat too quickly, choose fatty or rich food, or skip meals altogether. Loose stools and an unsettled stomach are common companions at this stage. Some people get constipation instead, or alternate between the two.
Fatigue, mild headaches and a general sense of being off-colour are also reported in the early weeks, and they're worth acknowledging, you're not imagining it, and you're not reacting badly in a way that means treatment is wrong for you. These effects typically reflect your gut adjusting to slower gastric emptying, one of semaglutide's core mechanisms. The semaglutide side-effect overview on this site covers the full documented list; here the focus is on the raw lived experience.
Practically, smaller meals, eating slowly, cutting back on alcohol and fatty food, and staying well hydrated all reduce the severity. Injection-site reactions (redness, a small lump, mild soreness) affect some people too and are generally short-lived. Rotating the injection site each week keeps this to a minimum.
Semaglutide works through a gradual dose titration: the starting dose is a tolerability step, and the prescription moves up in stages, typically every four weeks. Each upward step can bring a brief return of GI symptoms, nausea in particular tends to resurface for a week or so before settling again. This pattern repeats at each new dose level.
Knowing it's coming makes it more manageable. Most people find the peak maintenance dose far more comfortable than the first month suggested, because the body does adapt. The minority who don't find a given dose tolerable after a reasonable settling period would discuss that with their prescriber; the right response is a clinical conversation, not stopping abruptly. More detail on how long individual reactions last is covered in our guide to how long semaglutide side effects typically persist.
Reflux, burping and indigestion become more prominent for some people as the dose climbs, because gastric motility is slowing more substantially. Eating smaller portions, staying upright after meals and avoiding eating late in the evening all help. None of this is glamorous, but for most people it's manageable and temporary.
The majority of side effects from semaglutide are unpleasant rather than dangerous. A smaller number are serious enough to need prompt assessment.
Acute pancreatitis is the one the MHRA has specifically highlighted. In January 2026, the regulator issued a Drug Safety Update for GLP-1 medicines reminding prescribers and patients that pancreatitis, though infrequent, can occur. The symptom to know: severe, persistent abdominal pain that radiates through to the back, sometimes accompanied by vomiting. If that describes what you're experiencing, stop eating and seek urgent medical attention, don't wait to see if it passes.
Other reasons to get help promptly include signs of dehydration (dizziness, very dark urine, inability to keep fluids down) if prolonged vomiting or diarrhoea has been severe; symptoms of a serious allergic reaction such as facial swelling, difficulty breathing or a rapidly spreading rash; and any signs of gallbladder trouble such as sudden pain in the upper right abdomen, especially after eating. For more context on the more severe end of the spectrum, our page on the more serious semaglutide reactions goes into each one in detail.
If you're ever uncertain whether what you're experiencing needs attention, you can read more about each side effect of semaglutide on this site before contacting a pharmacist, your GP, or calling 111. Don't attempt to adjust the dose or timing yourself, that conversation belongs with your prescriber.
Wegovy (the brand name for semaglutide used in weight management) is a prescription-only medicine. Access through the NHS is subject to phased eligibility criteria under NICE guideline TA875, and waiting times through specialist services can be long. Private clinics and online pharmacies offer an alternative for people who meet the licensed eligibility criteria but don't qualify for NHS treatment yet, or prefer not to wait.
At nume, every consultation is read by a GPhC-registered Independent Prescriber the same day, a real clinician, not automated triage. Side effects, medical history, current medicines and suitability are part of that review; it's also the conversation where questions like the ones this page raises can get a direct answer tailored to your situation. Our clinical team oversees dispensing through our GPhC-registered pharmacy (registration 9012878, verifiable at the GPhC register). If you want to understand what treatment through a regulated service looks like from first consultation to delivery, our Wegovy treatment page covers the detail. Our prescribers discuss side-effect management and suitability as part of every consultation, check your eligibility to get started.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.